Definium Therapeutics, Inc. - Common Shares (DFTX) earnings
DFTX earnings moved a median of -0.99% by the close. Quarterly and annual DFTX reports and results, each read against the price at its own news timestamp. Back to the DFTX overview →
10 measured DFTX earnings events.
Where these DFTX earnings landedvs 10 measured DFTX earnings reactions
| Middle 50% of DFTX earnings reactions | -3.05% to +0.22% |
|---|---|
| Median reaction (to close) | -0.99% |
| Measured reactions | 10 |
Point-in-time · zero look-ahead
Half of the 10 DFTX earnings events with a measured close landed between -3.05% and +0.22%; 30% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Definium Therapeutics Reports Third Quarter 2026 Financial Results and Recent Highlights | Press release | -0.29% | +0.41% | |
| Form 10-Q Definium Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.29% | +0.41% | |
| Definium Therapeutics to Report Third Quarter 2026 Financial Results on November 9, 2026 | Press release | +0.93% | -2.44% | |
| Definium Therapeutics Reports Second Quarter 2026 Financial Results and Recent Highlights | Press release | +2.46% | -0.35% | |
| Form 10-Q Definium Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +2.46% | -0.35% | |
| Definium Therapeutics to Report Second Quarter 2026 Financial Results on August 6, 2026 | Press release | -1.91% | -3.25% | |
| Definium Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights | Press release | -4.18% | -3.54% | |
| Form 10-Q Definium Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -4.18% | -3.54% | |
| Definium Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026 | Press release | +0.14% | -1.63% | |
| Form 10-K Definium Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +3.62% | +2.59% |
Keep exploring
More DFTX: analyst actions → · SEC filings → · DFTX overview →